跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Piperazine Citrate
首页
药物
Piperazine Citrate
Piperazine Citrate
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Aildenafil citrate crystal form C and preparation method and application thereof
CN 101691372 B
申请人: GUIKUN LIU
优先权: 2009
CN
Compound capable of inhibiting phosphodiesterase type 5 and preparation method
CN 101891747 B
申请人: NAN ZHANG
优先权: 2010
CN
Buffers for stabilizing lentiviral formulations
CN 116162658 A
申请人: NOVARTIS AG
优先权: 2015
CN
Compound preparation for treating cholestatic jaundice and preparing method thereof
CN 105998052 A
申请人: XU HAIYAN
优先权: 2016
CN
Preparation method of sildenafil citrate
CN 108117555 A
申请人: GUANGZHOU PHARMA ORANGE BIOTECHNOLOGY CO LTD
优先权: 2018
CN
Compound albendazole suspension solution agent and preparation method thereof
CN 108524444 A
申请人: JIANGXI XINTIANDI PHARMACEUTICAL CO LTD
优先权: 2018
CN
Method for preparing sildenafil citrate
CN 111116591 A
申请人: TIANJIN KELUN PHARMACEUTICAL RES CO LTD
优先权: 2018
CN
Synthesis method of sildenafil citrate intermediate
CN 109970744 A
申请人: CHONGQING CONQUER PHARMACEUTICAL CO LTD
优先权: 2019
CN
Preparation method of tandospirone citrate
CN 121342806 A
申请人: JEWIM PHARMACEUTICAL SHANDONG CO LTD
优先权: 2025
CN
药物
反馈